Increased levels of soluble Fas ligand in CSF of rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis patients
✍ Scribed by Mineki Saito; Norio Nakamura; Masahiro Nagai; Kamon Shirakawa; Hironori Sato; Nobuko Kawahigashi; Yoshitaka Furukawa; Koichiro Usuku; Masanori Nakagawa; Shuji Izumo; Mitsuhiro Osame
- Book ID
- 114138897
- Publisher
- Elsevier Science
- Year
- 1999
- Tongue
- English
- Weight
- 93 KB
- Volume
- 98
- Category
- Article
- ISSN
- 0165-5728
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The oncoprotein Tax was characterized genetically from a large cohort of human T‐cell lymphotropic virus type 1 (HTLV‐1) seropositive individuals from the most endemic region of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) and HTLV‐1 infection in Argentina, the pr
## Abstract The human T‐cell lymphotropic virus type 1 (HTLV‐1) is the etiological agent of HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP), a progressive disease causing paraparesis of the lower limbs. Only a minority of persons infected with HTLV‐1 develop HAM/TSP. Universal s
## Abstract Human T‐lymphotropic virus 1 (HTLV‐1)‐associated myelopathy/tropical spastic paraparesis (HAM/TSP) is a complication that affects up to 5% of HTLV‐1‐infected individuals. Several host genetic and viral factors have been associated with the risk of HAM/TSP. The aim of this study was to e